Reply to: Prostate‐specific membrane antigen‐PET‐defined oligoprogressive castration‐resistant prostate cancer: is metastasis‐directed therapy ready for prime time?

Tobias Hölscher, Fabian Lohaus
BJU International · Wiley · 2026-10-27 · DOI: 10.1111/bju.70494

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles